Ardevora Asset Management LLP Regeneron Pharmaceuticals, Inc. Transaction History

Ardevora Asset Management LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 06, 2023	SELL	$700.03 - $830.35 $19 Million - $22.5 Million	-27,114 Reduced 28.62%	67,614 $48.6 Million
Q1 2023 Apr 20, 2023	BUY	$680.49 - $826.97 $1.77 Million - $2.15 Million	2,595 Added 2.82%	94,728 $77.8 Million
Q4 2022 Jan 12, 2023	BUY	$705.89 - $766.39 $65 Million - $70.6 Million	92,133 New	92,133 $66.5 Million
Q2 2018 Jul 30, 2018	SELL	$284.6 - $344.99 $22.3 Million - $27 Million	-78,300 Closed	0 $0
Q1 2018 May 08, 2018	BUY	$315.82 - $393.78 $189,492 - $236,267	600 Added 0.77%	78,300 $27 Million
Q4 2017 Feb 12, 2018	BUY	$358.63 - $469.95 $7.75 Million - $10.2 Million	21,600 Added 38.5%	77,700 $29.2 Million
Q3 2017 Nov 06, 2017	BUY	$431.38 - $504.0 $24.2 Million - $28.3 Million	56,100	56,100 $25.1 Million

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Ardevora Asset Management LLP, based on Form 13F filings with the SEC.

Stay updated on Ardevora Asset Management LLP with notifications on news.